https://www.selleckchem.com/pr....oducts/pacap-1-38.ht
Cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage (aSAH) is a major cause of high morbidity and mortality, for which there is no consistently effective treatment. Cervical spinal cord stimulation (cSCS) has been shown to induce vasodilatation and improve peripheral and cerebral blood flow in both animal and human studies. This pilot study was performed to assess the clinical effect and long-term results of cSCS treatment in aSAH patients. This was the first IRB- and US FDA-approved prospective non-randomized non-contro
Curtir
Comentario
Compartilhar
